The association between tramadol hydrochloride misuse and other substances use in an adolescent population: Phase I of a prospective survey

Addictive Behaviors

Volumn 39, Issue 1, 2014, Pages 333-337

  Nazarzadeh, Milad ^a,b   Bidel, Zeinab ^b   Carson, Kristin V ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Adolescents; Iran; Substances use; Tramadol

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CANNABIS; METHAMPHETAMINE; OPIATE; TRAMADOL;

ADOLESCENT; ADOLESCENT SMOKING; ADULT; ARTICLE; ASSOCIATION; DISEASE ASSOCIATION; DRUG MISUSE; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; SUBSTANCE ABUSE;

ADOLESCENTS; IRAN; SUBSTANCES USE; TRAMADOL;

ADOLESCENT; ALCOHOL DRINKING; AMPHETAMINE-RELATED DISORDERS; ANALGESICS, OPIOID; FEMALE; HUMANS; IRAN; MALE; MARIJUANA SMOKING; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; ODDS RATIO; OPIOID-RELATED DISORDERS; OPIUM; PRESCRIPTION DRUG MISUSE; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEX DISTRIBUTION; SUBSTANCE-RELATED DISORDERS; TRAMADOL;

EID: 84890225760     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.09.013     Document Type: Article

References (19)

1. Alireza Ayatollahi S., Mohammadpoorasl A., Rajaeifard A. Predicting the stages of smoking acquisition in the male students of Shiraz's high schools. Nicotine & Tobacco Research 2005, 7:845-851.
2. Babalonis S., Lofwall M.R., Nuzzo P.A., Siegel A.J., Walsh S.L. Abuse liability and reinforcing efficacy of oral tramadol in humans. Drug and Alcohol Dependence 2013, 129:116-124.
3. Dart R.C., Dasgupta N., Bailey J.E., Spiller H.A. Interpreting poison center call volume associated with tramadol. The Annals of Pharmacotherapy 2011, 45:424.
4. Duke A.N., Bigelow G.E., Lanier R.K., Strain E.C. Discriminative stimulus effects of tramadol in humans. Journal of Pharmacology and Experimental Therapeutics 2011, 338:255-262.
5. Iravani F.S., Akhgari M., Jokar F., Bahmanabadi L. Current trends in tramadol-related fatalities, Tehran, Iran 2005-2008. Substance Use & Misuse 2010, 45:2162-2171.
6. Kaplan C.P., Napoles-Springer A., Stewart S.L., Perez-Stable E.J. Smoking acquisition among adolescents and young Latinas: The role of socioenvironmental and personal factors. Addictive Behaviors 2001, 26:531-550.
7. Karrari P., Mehrpour O., Balali-Mood M. Iranian crystal: A misunderstanding of the crystal-meth. Journal of Research and Medical Science 2012, 17:203-204.
8. Lafta M. Tramadol dependence in the addiction unit of Baghdad: A cross sectional study. European Psychiatry 2011, 26:72.
9. Liu Z.M., Zhou W.H., Lian Z., Mu Y., Ren Z.H., Cao J.Q., et al. Drug dependence and abuse potential of tramadol. Zhongguo Yao Li Xue Bao 1999, 20:52-54.
10. Lord S., Brevard J., Budman S. Connecting to young adults: An online social network survey of beliefs and attitudes associated with prescription opioid misuse among college students. Substance Use & Misuse 2011, 46:66-76.
11. Minami K., Uezono Y., Ueta Y. Pharmacological aspects of the effects of tramadol on G-protein coupled receptors. Journal of Pharmacological Sciences 2007, 103:253-260.
12. Mintzer M.Z., Lanier R.K., Lofwall M.R., Bigelow G.E., Strain E.C. Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug and Alcohol Dependence 2010, 111:265-268.
13. Momtazi S., Rawson R. Substance abuse among Iranian high school students. Current Opinion in Psychiatry 2010, 23:221-226.
14. Nazarzadeh M., Bidel Z., Ayubi E., Bahrami A., Jafari F., Mohammadpoorasl A., et al. Smoking status in Iranian male adolescents: A cross-sectional study and a meta-analysis. Addictive Behaviors 2013, 38:2214-2218.
15. Senay E.C., Adams E.H., Geller A., Inciardi J.A., Munoz A., Schnoll S.H., et al. Physical dependence on Ultram (tramadol hydrochloride): Both opioid-like and atypical withdrawal symptoms occur. Drug and Alcohol Dependence 2003, 69:233-241.
16. Shadnia S., Soltaninejad K., Heydari K., Sasanian G., Abdollahi M. Tramadol intoxication: a review of 114 cases. Human & Experimental Toxicology 2008, 27:201-205.
17. Spiller H.A., Scaglione J.M., Aleguas A., Foster H., Durback-Morris L., Scharman E.J., et al. Effect of scheduling tramadol as a controlled substance on poison center exposures to tramadol. The Annals of Pharmacotherapy 2010, 44:1016-1021.
18. Taghaddosinejad F., Mehrpour O., Afshari R., Seghatoleslami A., Abdollahi M., Dart R.C. Factors related to seizure in tramadol poisoning and its blood concentration. Journal of Medical Toxicology 2011, 7:183-188.
19. Zabihi E., Hoseinzaadeh A., Emami M., Mardani M., Mahmoud B., Akbar M.A. Potential for tramadol abuse by patients visiting pharmacies in northern Iran. Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse 2011, 5:11-15.